First steps towards an understanding of a mode of carcinogenic action for vanadium pentoxide

Journal of Toxicologic Pathology

Volumn 24, Issue 3, 2011, Pages 149-162

  Schuler, Detlef ^a   Chevalier, Hans Jörg ^b   Merker, Mandy ^a   Morgenthal, Katja ^a   Ravanat, Jean Luc ^c   Sagelsdorff, Peter ^a   Walter, Marc ^a   Weber, Klaus ^a   McGregor, Douglas ^d  

^a Harlan   (Switzerland)

^b AnaPath GmbH   (Switzerland)

^c CEA GRENOBLE   (France)

^d TEC   (United Kingdom)

Author keywords

Comet assay; DNA lesions; Mouse inhalation; Oxidative stress; Vanadium pentoxide

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; 8 ISOPROSTANE; ALPHA TOCOPHEROL; GLUTATHIONE; VANADIUM PENTOXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CHEMICAL MUTAGENESIS; COMET ASSAY; CONTROLLED STUDY; DNA ADDUCT; DNA DAMAGE; FEMALE; HISTIOCYTOSIS; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; LUNG ALVEOLITIS; LUNG CARCINOGENESIS; LUNG INFILTRATE; LUNG LAVAGE; LUNG WEIGHT; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; TOXIC INHALATION; UPREGULATION;

EID: 83155172557     PISSN: 09149198     EISSN: None     Source Type: Journal    
DOI: 10.1293/tox.24.149     Document Type: Article

References (55)

1. Greenwood NN, and Earnshaw A. Chemistry of the Elements. In: Vanadium, Niobium and Tantalum, 2nd ed. Elsevier Science, Oxford. 985-1001. 1997.
2. Fukai R, and Meinke WW. Activation analyses of vanadium, arsenic, molybdenum, tungsten, rhenium, and gold in marine organisms. Limnol Oceanogr. 7: 186-200. 1962.
3. Hudson TGF. Vanadium: Toxicology and biological significance. In: Elsevier Monographs on Toxic Agents. Browning E (ed). 1st ed. Elsevier Publishing Company, Amsterdam. 67-78. 1964.
4. Nielsen FH. Nutritional requirements for boron, silicon, vanadium, nickel, and arsenic: current knowledge and speculation. FASEB J. 5: 2661-2667. 1991.
5. Rojas E, Herrera LA, Poirier LA, and Ostrosky-Wegman P. Are metals dietary carcinogens? Mutat Res. 443: 157-181. 1999.
6. Dimond EG, Caravaca J, and Benchimol A. Vanadium, excretion, toxicity, lipid effect in man. Am J Clin Nutr. 12: 49-53. 1963.
7. French RJ, and Jones PJ. Role of vanadium in nutrition: metabolism, essentiality and dietary considerations. Life Sci. 52: 339-346. 1993.
8. Woolery M. Vanadium compounds. In: Kirk-Othmer Encyclopedia of Chemical Technology Vol. 24, 4th ed. JI Kroschwitz, and M Howe-Grant (eds). John Wiley & Sons, New York. 797-811. 1997.
9. O'Neil MJ. The Merck Index, 13th ed. Whitehouse Station, NJ, Merck & Co. Inc. 1767. 2001.
10. IARC Cobalt in Hard Metals and Cobalt Sulfate, Gallium Arsenide, Indium Phosphide and Vanadium Pentoxide. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 86. Lyon. 227-292. 2006.
11. US National Toxicology Program Technical report on the studies of vanadium pentoxide (CAS no. 1314-62-1) in F344/N rats and B6C3F1 mice (inhalation studies). NTP TR 507, U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Toxicology Program, Research Triangle Park, NC. 2002.
12. Ress NB, Chou BJ, Renne RA, Dill JA, Miller RA, Roycroft JH, Hailey JR, Haseman JK, and Bucher JR. Carcinogenicity of inhaled vanadium pentoxide in F344/N rats and B6C3F1 mice. Toxicol Sci. 74: 287-296. 2003.
13. Assem FL, and Levy LS. A review of current toxicological concerns on vanadium pentoxide and other vanadium compounds: gaps in knowledge and directions for future research. J Toxicol Environ Health B Crit Rev. 12: 289-306. 2009.
14. Duffus JH. Carcinogenicity classification of vanadium pentoxide and inorganic vanadium compounds, the NTP study of carcinogenicity of inhaled vanadium pentoxide, and vanadium chemistry. Regul Toxicol Pharmacol. 47: 110-114. 2007.
15. Lindberg HK, Falck GC, Catalán J, Santonen T, and Norppa H. Micronucleus assay for mouse alveolar Type II and Clara cells. Environ Mol Mutagen. 51: 164-172. 2010.
16. Cannon WC, Blanton EF, and McDonald KE. The flow-past chamber: an improved nose-only exposure system for rodents. Am Ind Hyg Assoc J. 44: 923-928. 1983.
17. Griffith OW. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem. 106: 207-212. 1980.
18. Arnaud J, Fortis I, Blachier S, Kia D, and Favier A. Simultaneous determination of retinol, α-tocopherol and β-carotene in serum by high performance liquid chromatography. J Chromatogr. 572: 103-116. 1991.
19. nd LJ, and Burk RF. Formation of novel non-cyclooxygenase-derived prostanoids in carbon tetrachloride hepatotoxicity. J Clin Invest. 90: 2502-2507. 1992.
20. Ravanat JL, Douki T, Duez P, Gremaud E, Herbert K, Hofer T, Lasserre L, Saint-Pierre C, Favier A, and Cadet J. Cellular background level of 8-oxo-7,8-dihydro-2'-deoxyguanosine: an isotope based method to evaluate artefactual oxidation of DNA during its extraction and subsequent work-up. Carcinogenesis. 23: 1911-1918. 2002.
21. Klaunig JE, Xu Y, Isenberg JS, Bachowski S, Kolaja KL, Jiang J, Stevenson DE, and Walborg EF Jr. The role of oxidative stress in chemical carcinogenesis. Environ Health Perspect. 106: 289-295. 1998.
22. Ravanat JL, Duretz B, Guiller A, Douki T, and Cadet J. Isotope dilution high-performance liquid chromatography-electrospray tandem mass spectrometry assay for the measurement of 8-oxo-7,8-dihydro-2'-deoxyguanosine in biological samples. J Chromatogr B Biomed Sci Appl. 715: 349-356. 1998.
23. Frelon S, Douki T, Ravanat JL, Pouget JP, Tornabene C, and Cadet J. High performance liquid chromatography-tandem mass spectrometry for the measurement of radiation-induced base damage to isolated and cellular DNA. Chem Res Toxicol. 13: 1002-1010. 2000.
24. Rivière J, Ravanat JL, and Wagner JR. Ascorbate and H2O2 induced oxidative DNA damage in Jurkat cells. Free Radic Biol Med. 40: 2071-2079. 2006.
25. Regulus P, Duroux B, Bayle PA, Favier A, Cadet J, and Ravanat JL. Oxidation of the sugar moiety of DNA by ionizing radiation or bleomycin could induce the formation of a cluster DNA lesion. Proc Nat Acad Sci USA. 104: 14032-14037. 2007.
26. Douki T, Odin F, Caillat S, Favier A, and Cadet J. Predominance of the 1,N2-propano 2'-deoxyguanosine adduct among 4-hydroxy-2-nonenal-induced DNA lesions. Free Radic Biol Med. 37: 62-70. 2004.
27. Dill JA, Lee KM, Mellinger KH, Bates DJ, Burka LT, and Roycroft JH. Lung deposition and clearance of inhaled vanadium pentoxide in chronically exposed F344 rats and B6C3F1 mice. Toxicol Sci. 77: 6-18. 2004.
28. Crans DC, Zhang B, Gaidamauskas E, Keramidas AD, Willsky GR, and Roberts CR. Is vanadate reduced by thiols under biological conditions? Changing the redox potential of V(V)/V(IV) by complexation in aqueous solution. Inorg Chem. 49: 4245-4256. 2010.
29. Crans DC, Smee JJ, Gaidamauskas E, and Yang L. The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds. Chem Rev. 104: 849-902. 2004.
30. Frank P, Carlson EJ, Carlson RMK, Hedman B, and Hodgson KO. The uptake and fate of vanadyl ion in ascidian blood cells and a detailed hypothesis for the mechanism and location of biological vanadium reduction. A visible and X-ray absorption spectroscopic study. J. Inorg Biochem. 102: 809-823. 2008.
31. Rondini EA, Walters DM, and Bauer AK. Vanadium pentoxide induces pulmonary inflammation and tumor promotion in a strain-dependent manner. Part Fibre Toxicol. 7: 9-22. 2010.
32. Ames BN, Shigenaga MK, and Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA. 90: 7915-7922. 1993.
33. Ames BN, Gold LS, and Willett WC. The causes and prevention of cancer. Proc Natl Acad Sci USA. 92: 5258-5265. 1995.
34. Jaruga P, and Dizdaroglu M. Repair of products of oxidative DNA base damage in human cells. Nucleic Acids Res. 24: 1389-1394. 1996.
35. Spencer JP, Jenner A, Aruoma OI, Cross CE, Wu R, and Halliwell B. Oxidative DNA damage in human respiratory tract epithelial cells. Time course in relation to DNA strand breakage. Biochem Biophys Res Commun. 224: 17-22. 1996.
36. Minowa O, Arai T, Hirano M, Monden Y, Nakai S, Fukuda M, Itoh M, Takano H, Hippou Y, Aburatani H, Masumura K, Nohmi T, Nishimura S, and Noda T. Mmh/Ogg1 gene inactivation results in accumulation of 8-hydroxyguanine in mice. Proc Natl Acad Sci USA. 97: 4156-4161. 2000.
37. Cadet J, Douki T, Gasparutto D, and Ravanat JL. Oxidative damage to DNA: formation, measurement and biochemical features. Mutat Res. 531: 5-23. 2003.
38. Cadet J, and Téoule R. Comparative study of oxidation of nucleic acid components by hydroxyl radicals, singlet oxygen and superoxide anion radicals. Photochem Photobiol. 28: 661-665. 1978.
39. Ravanat JL, Martinez GR, Medeiros MGH, Di Mascio P, and Cadet J. Singlet oxygen oxidation of 2'-deoxyguanosine. Formation and mechanistic insights. Tetrahedron. 62: 10709-10715. 2006.
40. Ravanat JL, Sauvaigo S, Caillat S, Martinez GR, Medeiros MH, Di Mascio P, Favier A, and Cadet J. Singlet oxygen-mediated damage to cellular DNA determined by the comet assay associated with DNA repair enzymes. Biol Chem. 385: 17-20. 2004.
41. Bourdat AG, Douki T, Frelon S, Gasparutto D, and Cadet J. Tandem base lesions are generated by hydroxyl radical within isolated DNA in aerated aqueous solution. J Am Chem Soc. 122: 4549-4556. 2000.
42. Douki T, Rivière J, and Cadet J. DNA tandem base lesions containing 8-oxo-7,8-dihydroguanine and formamido residues arise from intramolecular addition of thymine peroxyl radical to guanine. Chem Res Toxicol. 15: 445-454. 2002.
43. Bergeron F, Auvré F, Radicella JP, and Ravanat JL. HO• radicals induce an unexpected high proportion of tandem base lesions refractory to repair by DNA glycosylases. Proc Nat Acad Sci USA. 107: 5528-5533. 2010.
44. Kasai H, Yamaizumi Z, Berger M, and Cadet J. Photosensitized formation of 7,8-dihydro-8-oxo-2'-deoxyguanosine (8-hydroxy-2'-deoxyguanosine) in DNA by riboflavin: a non singlet oxygen mediated mechanism. J Am Chem Soc. 114: 9692-9694. 1992.
45. Melvin T, Cunniffe SMT, O'Neill P, Parker AW, and Roldan-Arjona R. Guanine is the target for direct ionisation damage in DNA, as detected using excision enzymes. Nucleic Acids Res. 26: 4935-4942. 1998.
46. Mangal D, Vudathala D, Park JH, Lee SH, Penning TM, and Blair IA. Analysis of 7,8-dihydro-8-oxo-2'-deoxyguanosine in cellular DNA during oxidative stress. Chem Res Toxicol. 22: 788-797. 2009.
47. Osterod M, Hollenbach S, Hengstler JG, Barnes DE, Lindahl T, and Epe B. Age-related and tissue-specific accumulation of oxidative DNA base damage in 7,8-dihyro-8-oxoguanine-DNA glycosylase (Ogg1) deficient mice. Carcinogenesis. 22: 1459-1463. 2001.
48. Ivancsits S, Pilger A, Diem E, Schaffer A, and Rüdiger HW. Vanadate induces DNA strand breaks in cultured human fibroblasts at doses relevant to occupational exposure. Mutat Res. 519: 25-35. 2002.
49. Kleinsasser N, Dirschedl P, Staudenmaier R, Harréus U, and Wallner B. Genotoxic effects of vanadium pentoxide on human peripheral lymphocytes and mucosal cells of the upper aerodigestive tract. Int J Environ Health Res. 13: 373-379. 2003.
50. Rojas E, Valverde M, Herrera LA, Altamirano-Lozano M, and Ostrosky-Wegman P. Genotoxicity of vanadium pentoxide evaluate by the single cell gel electrophoresis assay in human lymphocytes. Mutat Res. 359: 77-84. 1996.
51. Ramírez P, Eastmond DA, Laclette JP, and Ostrosky-Wegman P. Disruption of microtubule assembly and spindle formation as a mechanism for the induction of aneuploid cells by sodium arsenite and vanadium pentoxide. Mutat Res. 386: 291-298. 1997.
52. Ciranni R, Antonetti M, and Migliore L. Vanadium salts induce cytogenetic effects in in vivo treated mice. Mutat Res. 343: 53-60. 1995.
53. Attia SM, Badary OA, Hamada FM, de Angelis MH, and Adler ID. Orthovanadate increased the frequency of aneuploid mouse sperm without micronucleus induction in mouse bone marrow erythrocytes at the same dose level. Mutat Res. 583: 158-167. 2005.
54. Villani P, Cordelli E, Leopardi P, Siniscalchi E, Veschetti E, Fresegna AM, and Crebelli R. Evaluation of genotoxicity of oral exposure to tetravalent vanadium in vivo. Toxicol Lett. 170: 11-18. 2007.
55. Saxena AK, Srivastava P, Kale RK, and Baquer NZ. Impaired antioxidant status in diabetic rat liver. Effect of vanadate. Biochem Pharmacol. 45: 539-542. 1993.